These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9707331)

  • 1. Incidence of neuronal perikaryal spheroids in neuronal ceroid lipofuscinoses (Batten disease).
    Elleder M; Tyynela J
    Clin Neuropathol; 1998; 17(4):184-9. PubMed ID: 9707331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipid activator proteins (SAPs) in neuronal ceroid lipofuscinoses (NCL).
    Tyynelä J; Suopanki J; Baumann M; Haltia M
    Neuropediatrics; 1997 Feb; 28(1):49-52. PubMed ID: 9151322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different patterns of hydrophobic protein storage in different forms of neuronal ceroid lipofuscinosis (NCL, Batten disease).
    Palmer DN; Jolly RD; van Mil HC; Tyynelä J; Westlake VJ
    Neuropediatrics; 1997 Feb; 28(1):45-8. PubMed ID: 9151321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ovine model of neuronal ceroid lipofuscinosis (NCL): its contribution to understanding the pathogenesis of Batten disease.
    Jolly RD
    Neuropediatrics; 1997 Feb; 28(1):60-2. PubMed ID: 9151325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipid activator proteins (SAPs) are stored together with glycosphingolipids in the infantile neuronal ceroid-lipofuscinosis (INCL).
    Tyynelä J; Baumann M; Henseler M; Sandhoff K; Haltia M
    Am J Med Genet; 1995 Jun; 57(2):294-7. PubMed ID: 7668348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased lysosomal subunit c-degrading activity in fibroblasts from patients with late infantile neuronal ceroid lipofuscinosis.
    Ezaki J; Wolfe LS; Kominami E
    Neuropediatrics; 1997 Feb; 28(1):53-5. PubMed ID: 9151323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light and electron microscopic studies on subunit c in cultured fibroblasts in late infantile and juvenile Batten disease.
    Lake BD; Rowan SA
    Neuropediatrics; 1997 Feb; 28(1):56-9. PubMed ID: 9151324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders.
    Elleder M; Sokolová J; Hrebícek M
    Acta Neuropathol; 1997 Apr; 93(4):379-90. PubMed ID: 9113203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroid-lipofuscinosis.
    Palmer DN; Tyynelä J; van Mil HC; Westlake VJ; Jolly RD
    J Inherit Metab Dis; 1997 Mar; 20(1):74-84. PubMed ID: 9061571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topographic variabilities of immunoreactivity to subunit c of mitochondrial ATP synthase and lectin binding in late infantile neuronal ceroid-lipofuscinosis.
    Kida E; Wisniewski KE; Connell F
    Am J Med Genet; 1995 Jun; 57(2):182-6. PubMed ID: 7668327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in neuropathology of the neuronal ceroid lipofuscinoses.
    Goebel HH; Schochet SS; Jaynes M; Brück W; Kohlschütter A; Hentati F
    Mol Genet Metab; 1999 Apr; 66(4):367-72. PubMed ID: 10191130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry of neuronal ceroid lipofuscinoses.
    Junaid MA; Pullarkat RK
    Adv Genet; 2001; 45():93-106. PubMed ID: 11332778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnoses of neuronal ceroid-lipofuscinosis by immunochemical methods.
    Hosain S; Kaufmann WE; Negrin G; Watkins PA; Siakotos AN; Palmer DN; Naidu S
    Am J Med Genet; 1995 Jun; 57(2):239-45. PubMed ID: 7668338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-specific pathology in neurons cultured from sheep affected with ceroid lipofuscinosis.
    Hughes SM; Kay GW; Jordan TW; Rickards GK; Palmer DN
    Mol Genet Metab; 1999 Apr; 66(4):381-6. PubMed ID: 10191133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses: an immunological study.
    Tyynelä J; Baumann M; Henseler M; Sandhoff K; Haltia M
    Acta Neuropathol; 1995; 89(5):391-8. PubMed ID: 7618436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of neuronal ceroid lipofuscinosis (Batten disease) by electron microscopy in peripheral blood specimens.
    Anderson GW; Smith VV; Brooke I; Malone M; Sebire NJ
    Ultrastruct Pathol; 2006; 30(5):373-8. PubMed ID: 17090516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal ceroid lipofuscinosis: clinical and morphologic findings in nine affected Polish Owczarek Nizinny (PON) dogs.
    Narfström K; Wrigstad A; Ekesten B; Berg AL
    Vet Ophthalmol; 2007; 10(2):111-20. PubMed ID: 17324167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Batten disease and the ATP synthase subunit c turnover pathway: raising antibodies to subunit c.
    Palmer DN; Bayliss SL; Westlake VJ
    Am J Med Genet; 1995 Jun; 57(2):260-5. PubMed ID: 7668342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuronal ceroid lipofuscinosis. Closing chapter of a long story].
    Elleder M
    Cesk Patol; 2000 May; 36(2):43-59. PubMed ID: 10916928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A form of juvenile Batten disease with granular osmiophilic deposits.
    Lake BD; Brett EM; Boyd SG
    Neuropediatrics; 1996 Oct; 27(5):265-9. PubMed ID: 8971748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.